Upregulation of Mitochondrial Transcription Factor A Promotes the Repairment of Renal Tubular Epithelial Cells in Sepsis by Inhibiting Reactive Oxygen Species-Mediated Toll-Like Receptor 4/p38MAPK Signaling

作者: Xin-Gui Dai , Tao Li , Wei-Bo Huang , Zhen-Hua Zeng , Qiong Li

DOI: 10.1159/000501789

关键词:

摘要: Background Mitochondrial transcription factor A (TFAM) plays multiple pathophysiologic roles in mitochondrial DNA (mtDNA) maintenance. However, the role of TFAM sepsis-induced acute kidney injury (AKI) remains largely unknown. Methods Lipopolysaccharide (LPS) treatment HK-2 cells mimics vitro model AKI inflammation. pcDNA3.1 plasmid was used to construct pcDNA3.1-TFAM. sh-TFAM-543, sh-TFAM-717, sh-TFAM-765, sh-TFAM-904 and pcDNA3.1-TFAM were transfected into using Lipofectamine 2000. MtDNA transcriptional levels detected by quantitative real-time polymerase chain reaction (qRT-PCR). 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide (MTT) assay performed assess cell viability. Changes reactive oxygen species (ROS) membrane potential corresponding kits. Immunofluorescence experiment investigate displacement TFAM. mRNA protein expression its related genes measured qRT-PCR western blot respectively. Mice sepsis administered cecal ligation puncture surgery. Results LPS a non-lethal influencing factor, leading upregulation ROS downregulation mtDNA copy number NADH dehydrogenase subunit-1 (ND1) expression, caused damage mitochondria. As time increased, displaced from periphery nucleus cytoplasm. reduced P38MAPK inhibiting toll-like receptor 4 (TLR4) ultimately inflammation repairing mtDNA. Conclusions Our results indicate that repairs blocking TLR4/ROS/P38MAPK signaling pathway inflammatory cells, thereby septic tubular epithelial may serve as new target for therapy.

参考文章(41)
Alina Toma, Angela Stone, Robert S Green, Sara Gray, None, Steroids for patients in septic shock: the results of the CORTICUS trial. Canadian Journal of Emergency Medicine. ,vol. 13, pp. 273- 276 ,(2011) , 10.2310/8000.2011.110243
Hiroshi Ishiguchi, Takayuki Torigoe, Hiroto Izumi, Dongchon Kang, Yoichiro Yoshida, Kimitoshi Kohno, Hideaki Itoh, P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Research. ,vol. 63, pp. 3729- 3734 ,(2003)
Makiko Yoshino, Ayano Naka, Yuri Sakamoto, Ayako Shibasaki, Mariko Toh, Sakuka Tsukamoto, Kazuo Kondo, Kaoruko Iida, Dietary isoflavone daidzein promotes Tfam expression that increases mitochondrial biogenesis in C2C12 muscle cells. Journal of Nutritional Biochemistry. ,vol. 26, pp. 1193- 1199 ,(2015) , 10.1016/J.JNUTBIO.2015.05.010
Jun-Feng Chen, Hong Liu, Hai-Feng Ni, Lin-Li Lv, Ming-Hui Zhang, Ai-Hua Zhang, Ri-Ning Tang, Ping-Sheng Chen, Bi-Cheng Liu, Improved Mitochondrial Function Underlies the Protective Effect of Pirfenidone against Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats PLoS ONE. ,vol. 8, pp. e83593- ,(2013) , 10.1371/JOURNAL.PONE.0083593
Elliott D. Crouser, Guohong Shao, Mark W. Julian, Jennifer E. Macre, Gerald S. Shadel, Susheela Tridandapani, Qin Huang, Mark D. Wewers, Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Critical Care Medicine. ,vol. 37, pp. 2000- 2009 ,(2009) , 10.1097/CCM.0B013E3181A001AE
Todd A. Gangelhoff, Purnima S. Mungalachetty, Jay C. Nix, Mair E. A. Churchill, Structural analysis and DNA binding of the HMG domains of the human mitochondrial transcription factor A Nucleic Acids Research. ,vol. 37, pp. 3153- 3164 ,(2009) , 10.1093/NAR/GKP157
Xiaocheng Dong, Kalpana Ghoshal, Sarmila Majumder, Satya P. Yadav, Samson T. Jacob, Mitochondrial transcription factor A and its downstream targets are up-regulated in a rat hepatoma Journal of Biological Chemistry. ,vol. 277, pp. 43309- 43318 ,(2002) , 10.1074/JBC.M206958200
Dieter Mesotten, Marijke Gielen, Caroline Sterken, Kirsten Claessens, Greet Hermans, Dirk Vlasselaers, Jurgen Lemiere, Lieven Lagae, Marc Gewillig, Benedicte Eyskens, Ilse Vanhorebeek, Pieter J. Wouters, Greet Van den Berghe, Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA. ,vol. 308, pp. 1641- 1650 ,(2012) , 10.1001/JAMA.2012.12424